Gilead Treatment Promising But No Silver Bullet Yet (Podcast)

·

·

Gilead Treatment Promising But No Silver Bullet Yet (Podcast)

Brooke Sutherland, Bloomberg Opinion Industrials columnist, on the stark reality for Boeing. Hosted by Lisa Abramowicz and Paul Sweeney. Running
See Original Article

Pinned To Zero: Fed Funds Rate To Stay Low "Until Full Employment” Is Back In Sight

Key Takeaways: Fed leaves rates unchanged, as expected, promising to keep them at zero; Rates won’t rise again until full employment, inflation return, Fed says; Market rallies despite gloomy Fed picture as investors focus on drug trials. Today’s Fed meeting …
See Original Article

US Pending Home Sales Plunge Most Since 2010 on Virus Fallout

The median forecast in a Bloomberg survey of economists called for a decrease of 13.6%. Compared with a year earlier, contract signings dropped
See Original Article

No, an artificial intelligence can't legally invent something — only 'natural persons' can, says US patent office

AI systems can’t legally be considered inventors on patents, the US Trademark and Patent Office announced Monday, as first reported by The Verge. A group of patent lawyers had argued that a “creativity machine,” called DABUS, should be listed as an …
See Original Article

Gilead Treatment Promising But No Silver Bullet Yet (Radio)

Sam Fazeli, Director of Research: EMEA for Bloomberg Intelligence, on Gilead's positive trial for a potential coronavirus treatment. Hosted by Lisa
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.